BlackRock Advisors’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$25.7M Buy
938,370
+98,442
+12% +$2.7M 0.03% 442
2016
Q3
$51.6M Buy
839,928
+697,122
+488% +$42.8M 0.05% 303
2016
Q2
$2.72M Buy
142,806
+108,221
+313% +$2.06M ﹤0.01% 1294
2016
Q1
$675K Sell
34,585
-23,877
-41% -$466K ﹤0.01% 1903
2015
Q4
$2.26M Sell
58,462
-586,557
-91% -$22.6M ﹤0.01% 1341
2015
Q3
$20.7M Buy
645,019
+20,973
+3% +$673K 0.02% 502
2015
Q2
$19M Buy
624,046
+18,837
+3% +$573K 0.02% 530
2015
Q1
$8.04M Buy
605,209
+231,546
+62% +$3.07M 0.01% 834
2014
Q4
$5.41M Buy
373,663
+350,567
+1,518% +$5.07M 0.01% 936
2014
Q3
$487K Sell
23,096
-97,225
-81% -$2.05M ﹤0.01% 1969
2014
Q2
$3.58M Buy
120,321
+94,764
+371% +$2.82M ﹤0.01% 1016
2014
Q1
$614K Buy
25,557
+1,355
+6% +$32.6K ﹤0.01% 1887
2013
Q4
$493K Buy
24,202
+4,125
+21% +$84K ﹤0.01% 2033
2013
Q3
$948K Buy
20,077
+1,143
+6% +$54K ﹤0.01% 1446
2013
Q2
$720K Buy
+18,934
New +$720K ﹤0.01% 1553